DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIESIS-STIMULATING AGENTS IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Laliberte, Francois [1 ]
Lafeuille, Marie-Helene [1 ]
Bailey, Robert A. [2 ]
Senbetta, Mekre [2 ]
McKenzie, R. Scott [2 ]
Dea, Katherine [1 ]
Lefebvre, Patrick [1 ]
机构：
[1] Grp Anal, Montreal, PQ, Canada
[2] Centocor Ortho Biotech Serv LLC, Bridgewater, NJ USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2010年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
38
引用
收藏
页码：A41 / A41
页数：1
相关论文
共 50 条
  • [1] Effect of erythropoiesis-stimulating agents on Healthcare utilization, costs, and outcomes in chronic kidney disease
    Maddux, Franklin W.
    Shetty, Sharashchandra
    Del Aguila, Michael A.
    Nelson, Michael A.
    Murray, Brian M.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) : 1761 - 1769
  • [2] ERYTHROPOIESIS-STIMULATING AGENTS UTILIZATION AND COSTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS FROM TWO LARGE CLAIMS DATABASES
    Lafeuille, M. H.
    Bailey, R. A.
    Laliberte, F.
    Senbetta, M.
    Blacksmith, A.
    Lefebvre, P.
    VALUE IN HEALTH, 2010, 13 (03) : A77 - A77
  • [3] Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
    Shah, Hitesh H.
    Fishbane, Steven
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 267 - 271
  • [4] Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer
    Hazzan, Azzour D.
    Shah, Hitesh H.
    Hong, Susana
    Sakhiya, Vipulbhai
    Wanchoo, Rimda
    Fishbane, Steven
    KIDNEY INTERNATIONAL, 2014, 86 (01) : 34 - 39
  • [5] Assessment of drug utilization patterns and costs for erythropoietic stimulating agents in patients with chronic kidney disease
    Lefebvre, Patrick
    Lalibert, Francois
    Lafeuille, Marie-Helene
    Bookhart, Brahim
    McKenzie, R. Scott
    Corral, Mitra
    Piech, Catherine
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A62 - A62
  • [6] DRUG UTILIZATION AND COSTS FOR ERYTHROPOIETIS STIMULATING AGENTS IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE IN MANAGED CARE
    Lafeuille, Marie-Helene
    Bailey, Robert A.
    McKenzie, R. Scott
    Vekeman, Francis
    Piech, Catherine Tak
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A49 - A49
  • [7] Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
    Palmer, Suetonia C.
    Navaneethan, Sankar D.
    Craig, Jonathan C.
    Johnson, David W.
    Tonelli, Marcello
    GargMd, Amit X.
    Pellegrini, Fabio
    Ravani, Pietro
    Jardine, Meg
    Perkovic, Vlado
    Graziano, Giusi
    McGee, Richard
    Nicolucci, Antonio
    Tognoni, Gianni
    Strippoli, Giovanni F. M.
    ANNALS OF INTERNAL MEDICINE, 2010, 153 (01) : 23 - W23
  • [8] Modulation of Platelet Activation in Chronic Kidney Disease Patients on Erythropoiesis-Stimulating Agents
    Farag, Youssef M. K.
    Keithy-Reddy, Sai Ram
    Mittal, Bharati V.
    Bansal, Vinod
    Fareed, Jaweed
    Singh, Ajay K.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (05) : 453 - 461
  • [9] Responsiveness to erythropoiesis-stimulating agents and renal survival in patients with chronic kidney disease
    Kuwahara, Michio
    Mandai, Shintaro
    Kasagi, Yuri
    Kusaka, Keita
    Tanaka, Tomomi
    Shikuma, Satomi
    Akita, Wataru
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (04) : 598 - 605
  • [10] Assessment of drug utilization patterns and costs for erythropoietic stimulating agents in elderly patients with chronic kidney disease
    Lafeuille, M. H.
    Lefebvre, P.
    Bookhart, B.
    Laliberte, F.
    Bailey, R.
    Corral, M.
    Piech, C. T.
    VALUE IN HEALTH, 2008, 11 (03) : A23 - A23
12345